DaVita CEO Kent Thiry steps down and is named executive chair of board of directors
DaVita Inc. announced its board of directors has unanimously elected Javier J. Rodriguez to succeed Kent J. Thiry as CEO of DaVita, effective June 1.
Rodriguez will also join the DaVita board of directors, and Thiry will transition from his current role as chair and CEO to executive chair of DaVita's board of directors.
“I am excited that Javier Rodriguez, with whom I have partnered for 20 years, will succeed me,” Thiry said in a press release. “The village is in a strong position for the next chapter, and Javier is the right person to build on our foundation and take us to the next level of clinical and economic performance.”
Thiry has been CEO of DaVita since 1999 and chair or co-chair of the board during that time. He has led the company’s growth, with close to 3,000 dialysis centers operating in 10 countries.
"I am honored to be the next CEO of DaVita, and I greatly appreciate the confidence that both Kent and the board have placed in me,” Rodriguez said in the release. “I also want to thank Kent for his leadership and continued support as executive chairman. DaVita is positioned well to execute on significant opportunities ahead and I look forward to working with the team on the next phase of our evolution to benefit our patients, teammates, physician partners and health care community as a whole.”
Prior to assuming the role of CEO of DaVita Kidney Care in 2014, Rodriguez served in several leadership and executive roles since joining the company in 1998, including president of DaVita Kidney Care from 2012 to 2014. Before joining the company, Rodriguez worked for Baxter Health Care Corporation.
DaVita is expected to announce its 2019 first-quarter earnings on May 7.